ACHV News and Press, Achieve Life Sciences Inc. From 08/03/20

SEATTLE and VANCOUVER, BC, Aug. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced a...

Gainers:  Marathon Patent (NASDAQ: MARA ) +107% . More news on: Marathon Patent Group, Inc., Datasea Inc., ADT Inc., Stocks on the move, , Read more ...

Achieve Life Sciences (NASDAQ: ACHV ) receives U.S. patent for its  novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...

Achieve Life Sciences (NASDAQ: ACHV ) files for 1-for-20 reverse stock split, effective market open today. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...

SEATTLE and VANCOUVER, British Columbia , July 31, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the Uni...

4 Penny Stocks To Watch This Month One of the best parts about penny stocks is that there are thousands of them. Seriously, think about it. If you miss a breakout on one penny stock, there are plenty more to watch that have a real chance of big moves, regardless. It’s one of the reaso...

Achieve Life Sciences to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020 Canada NewsWire SEATTLE and VANCOUVER, British Columbia, July 28, 2020 SEATTLE and VANCOUVER, British Columbia , July 28, 2020 /CNW/ -- ...

4 Penny Stocks To Watch Before The 4th Of July Holiday Weekend We’re heading into a unique week for all penny stocks , blue-chips , etc. Not only is it going to be the end of the month and second quarter, it’s also a short week that kicks off July and Q3. Given this as the case...

Achieve Life Sciences (NASDAQ: ACHV )  +6.10%  PM, entered into a securities purchase agreement for purchase and sale of 14.63M shares at a price of $0.41 per share in a registered direct offering, resulting in total gross proceeds of ~$6M. More news on: Achieve Life Sciences, ...

SEATTLE and VANCOUVER, BC , June 29, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announce...